ClearPoint Neuro Inc (CLPT)
5.94
+0.07
(+1.19%)
USD |
NASDAQ |
May 06, 16:00
5.94
0.00 (0.00%)
After-Hours: 20:00
ClearPoint Neuro Max Drawdown (5Y): 93.68% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 93.68% |
| March 31, 2024 | 94.08% |
| February 29, 2024 | 94.08% |
| January 31, 2024 | 95.04% |
| December 31, 2023 | 95.04% |
| November 30, 2023 | 95.11% |
| October 31, 2023 | 97.01% |
| September 30, 2023 | 97.45% |
| August 31, 2023 | 97.45% |
| July 31, 2023 | 97.45% |
| June 30, 2023 | 97.85% |
| May 31, 2023 | 97.85% |
| April 30, 2023 | 97.85% |
| March 31, 2023 | 97.85% |
| February 28, 2023 | 97.85% |
| January 31, 2023 | 97.85% |
| December 31, 2022 | 97.85% |
| November 30, 2022 | 97.85% |
| October 31, 2022 | 97.85% |
| September 30, 2022 | 97.85% |
| August 31, 2022 | 97.85% |
| July 31, 2022 | 97.85% |
| June 30, 2022 | 97.85% |
| May 31, 2022 | 98.19% |
| April 30, 2022 | 98.27% |
| Date | Value |
|---|---|
| March 31, 2022 | 98.27% |
| February 28, 2022 | 98.27% |
| January 31, 2022 | 98.27% |
| December 31, 2021 | 98.27% |
| November 30, 2021 | 98.76% |
| October 31, 2021 | 98.76% |
| September 30, 2021 | 98.76% |
| August 31, 2021 | 98.81% |
| July 31, 2021 | 98.81% |
| June 30, 2021 | 98.81% |
| May 31, 2021 | 98.81% |
| April 30, 2021 | 98.81% |
| March 31, 2021 | 98.81% |
| February 28, 2021 | 98.81% |
| January 31, 2021 | 98.81% |
| December 31, 2020 | 98.81% |
| November 30, 2020 | 98.81% |
| October 31, 2020 | 98.81% |
| September 30, 2020 | 98.81% |
| August 31, 2020 | 98.81% |
| July 31, 2020 | 98.81% |
| June 30, 2020 | 98.81% |
| May 31, 2020 | 98.81% |
| April 30, 2020 | 98.81% |
| March 31, 2020 | 98.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.68%
Minimum
Apr 2024
98.81%
Maximum
May 2019
98.02%
Average
98.76%
Median
Sep 2021
Max Drawdown (5Y) Benchmarks
| icad Inc | 94.63% |
| Perspective Therapeutics Inc | 91.70% |
| Xtant Medical Holdings Inc | 98.66% |
| Asensus Surgical Inc | 99.68% |
| Catheter Precision Inc | 100.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 0.9696 |
| Beta (5Y) | 0.9711 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 73.02% |
| Historical Sharpe Ratio (5Y) | 0.1615 |
| Historical Sortino (5Y) | 0.4109 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 24.41% |